Randomized comparative study of immediate CAB (combined androgen blockade) therapy and differed CAB therapy for stage B to D2 prostate cancer
Not Applicable
- Conditions
- prostate cancer
- Registration Number
- JPRN-UMIN000015161
- Lead Sponsor
- Kansai Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1) high ALP> x2.5 WNL 2)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival, (time to progression (CRPC))
- Secondary Outcome Measures
Name Time Method